Dahlia Medical Communications

Tag: dialysis

  • Vadadustat Essentials for Healthcare Professionals

    —

    by

    Rachael Hills
    in

    What is vadadustat?1 The FDA approved vadadustat (Vafseo®) in March 2024 for the treatment of anemia due to chronic kidney disease (CKD). Vadadustat is only approved for dialysis dependent CKD patients. It is not indicated to replace blood transfusions. What is vadadustat’s mechanism of action? Vadadustat is a hypoxia-inducible factor prolyl hydroxylase (HIF PF) inhibitor.…

  • Vadadustat Basics for Patients

    —

    by

    Rachael Hills
    in

    Disclaimer: Patients should review this guide before discussing vadadustat with their healthcare provider. Patients should always discuss potential medication changes and additions with their healthcare provider. What is vadadustat? Vadadustat (Vafseo®) is a new drug from Akebia Therapeutics, Inc. The FDA approved it for the treatment of anemia caused by chronic kidney disease (CKD).1 Vadadustat…